Steven E. Arnold, MD
Affiliations: | Center for Neurobiology and Behavior | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Cellular and molecular neurobiology of schizophrenia and mood disorders, aging and neurodegenerative dementiasWebsite:
http://www.med.upenn.edu/ins/faculty/arnold.htmGoogle:
"Steven Arnold"Mean distance: 18.32 (cluster 19)
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kivisäkk P, Carlyle BC, Sweeney T, et al. (2023) Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment. Frontiers in Neurology. 14: 1069411 |
| Quinn JP, Ethier EC, Novielli A, et al. (2023) Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer's Disease. Journal of the American Society For Mass Spectrometry |
| Azami H, Moguilner S, Penagos H, et al. (2023) EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Ko YA, Billheimer JT, Lyssenko NN, et al. (2022) ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's disease. Alzheimer's Research & Therapy. 14: 194 |
| Azami H, Chang Z, Arnold SE, et al. (2022) Detection of Oculomotor Dysmetria From Mobile Phone Video of the Horizontal Saccades Task Using Signal Processing and Machine Learning Approaches. Ieee Access : Practical Innovations, Open Solutions. 10: 34022-34031 |
| Carlyle BC, Kandigian SE, Kreuzer J, et al. (2021) Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiology of Aging. 105: 99-114 |
| Fong TG, Vasunilashorn SM, Gou Y, et al. (2021) Association of CSF Alzheimer's disease biomarkers with postoperative delirium in older adults. Alzheimer's & Dementia (New York, N. Y.). 7: e12125 |
| Schwab NA, DesRuisseaux LA, Weinberg MS, et al. (2020) Saving cognitive outcome data in Alzheimer's disease clinical trials during the COVID-19 pandemic: Commentary on the virtual administration of the ADAS-Cog. Alzheimer's & Dementia (New York, N. Y.). 6: e12081 |
| DesRuisseaux LA, Williams VJ, McManus AJ, et al. (2020) A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment. Trials. 21: 1016 |
| Bryant AG, Hu M, Carlyle BC, et al. (2020) Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease. Frontiers in Neurology. 11: 575953 |